相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers
Michael E. Rothenberg et al.
CLINICAL DRUG INVESTIGATION (2019)
Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects
Joshua D. Vardigan et al.
JOURNAL OF PAIN RESEARCH (2018)
Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective
Harvey Wong et al.
DRUG DISCOVERY TODAY (2017)
High-Throughput Screening of NaV1.7 Modulators Using a Giga-Seal Automated Patch Clamp Instrument
Chris Chambers et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
DE Moulin et al.
Pain Research & Management (2016)
Olfactory Sensitivity in Mammalian Species
M. Wackermannova et al.
PHYSIOLOGICAL RESEARCH (2016)
Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery
Tjerk Bueters et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Functional imaging of olfaction by CBV fMRI in monkeys: Insight into the role of olfactory bulb in habituation
Fuqiang Zhao et al.
NEUROIMAGE (2015)
Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain
Jacinthe Gingras et al.
PLOS ONE (2014)
Population PKPD Modeling of BACE1 Inhibitor-Induced Reduction in Aβ Levels In Vivo and Correlation to In Vitro Potency in Primary Cortical Neurons from Mouse and Guinea Pig
Juliette Janson et al.
PHARMACEUTICAL RESEARCH (2014)
The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives
Tjerk Bueters et al.
DRUG DISCOVERY TODAY (2013)
The NaV1.7 sodium channel: from molecule to man
Sulayman D. Dib-Hajj et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Olfactory Sensitivity for Six Predator Odorants in CD-1 Mice, Human Subjects, and Spider Monkeys
Amir Sarrafchi et al.
PLOS ONE (2013)
In Vivo and Ex Vivo Inhibition of Spinal Nerve Ligation-Induced Ectopic Activity by Sodium Channel Blockers Correlate to In Vitro Inhibition of NaV1.7 and Clinical Efficacy: A Pharmacokinetic-Pharmacodynamic Translational Approach
Ivana Kalezic et al.
PHARMACEUTICAL RESEARCH (2013)
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
Paul Morgan et al.
DRUG DISCOVERY TODAY (2012)
Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn
Joel A. Black et al.
MOLECULAR PAIN (2012)
Establishing the Relationship between In Vitro Potency, Pharmacokinetic, and Pharmacodynamic Parameters in a Series of Orally Available, Hydroxyethylamine-Derived β-Secretase Inhibitors
Stephen Wood et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons
Hye-Sook Ahn et al.
MOLECULAR PAIN (2011)
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia
Jan Weiss et al.
NATURE (2011)
Familial pain syndromes from mutations of the Na(v)1.7 sodium channel
Tanya Z. Fischer et al.
YEAR IN NEUROLOGY 2 (2010)
Optimising in vivo pharmacology studies-Practical PKPD considerations
Johan Gabrielsson et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Voltage-Gated Sodium Channels: Therapeutic Targets for Pain
Sulayman D. Dib-Hajj et al.
PAIN MEDICINE (2009)
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders
Joost P. H. Drenth et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
From genes to pain:: Nav1.7 and human pain disorders
Sulayman D. Dib-Hajj et al.
TRENDS IN NEUROSCIENCES (2007)
Sodium channel blockade may contribute to the analgesic efficacy of antidepressants
Ivy E. Dick et al.
JOURNAL OF PAIN (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
On the scent of human olfactory orbitofrontal cortex: Meta-analysis and comparison to non-human primates
JA Gottfried et al.
BRAIN RESEARCH REVIEWS (2005)
Dexmedetomidine pharmacodynamics: Part II - Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers
LI Cortinez et al.
ANESTHESIOLOGY (2004)
Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers
BP Murthy et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The glucose transporter GLUT1 and the tight junction protein occludin in nasal olfactory mucosa
P Hussar et al.
CHEMICAL SENSES (2002)
Relative potency of epidural to intrathecal clonidine differs between acute thermal pain and capsaicin-induced allodynia
JC Eisenach et al.
PAIN (2000)
分享论文
